Most Recent
IVF Australia faces multimillion dollar lawsuit over inaccurate genetic test
Fertility clinic IVF Australia is facing a lawsuit worth "many millions of dollars" launched by the parents of a child born with Pallister-Kilian syndrome, alleging it did not carry out a vital pre-implantation diagnostic test that would have identified the disease.
Settlement attempts in GetSwift class action like flogging a dead horse, court hears
Further attempts to settle a securities class action against last mile logistics software firm GetSwift would be like flogging a dead horse, a judge has heard as the matter works its way towards a final hearing.
Law firm can’t delay appeal over unpaid bill because QC won’t fly without vaccine
Law firm Atanaskovic Hartnell has failed to postpone its appeal of a ruling over unpaid legal fees until after its senior counsel -- who is stuck in London -- can get a COVID-19 vaccine and return to Australia.
CBA cops to misleading customers on more than 12,000 occasions
Commonwealth Bank of Australia could be on the hook for a large penalty after the court found the bank engaged in misleading and deceptive conduct and violated its financial services obligations on more than 12,000 occasions by overcharging customers more than $2.2 million in interest.
Tax adviser hit with record $22.7M fine over R&D tax scheme
A tax agent and accountant who conducted multiple tax exploitation schemes between 2011 and 2015 has been hit with a $22.7 million penalty, the largest ever against a tax promotor.
PwC takes swipe at class action over $50M bond prospectus
PricewaterhouseCoopers is looking to shut down a class action by irate bondholders of collapsed asset finance lender Axsesstoday Limited over alleged misrepresentations in a $50 million bond offer.
Full Court hears government’s $325M fight with Sanofi over ban on Plavix generic
Pharmaceutical companies Sanofi and Bristol-Myers Squibb are liable for losses to the federal government for excess subsidies it allegedly paid for the blood-thinner Plavix after an unjustified court injunction prevented the release of a generic version of the top-selling drug, an appeals court has heard.
$37.75M settlement reached in Estia Health class action
A $37.75 million settlement has been reached in a shareholder class action against Estia Health that accused the aged care provider of failing to disclose difficulties in its 2015 and 2016 acquisition strategy.
Merck Sharpe & Dohme sues Sandoz to block Januvia generic
US pharmaceutical giant Merck Sharp & Dohme has taken Sandoz to court for allegedly threatening to infringe the patent for its multibillion-dollar diabetes drugs Janumet and Januvia.
GetSwift slammed for ‘unfair attack’ on judge hearing class action, ASIC case
GetSwift has been criticised for its "quite unfair attack" on a Federal Court judge who refused to disqualify himself from hearing a shareholder class action against the logistics software company after presiding over ASIC's civil penalty proceeding against the company.